Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Notes Payables (2019 - 2021)

Silo Pharma's Notes Payables history spans 3 years, with the latest figure at $18900.0 for Q3 2021.

  • For Q3 2021, Notes Payables rose 160.4% year-over-year to $18900.0; the TTM value through Sep 2021 reached $18900.0, up 160.4%, while the annual FY2020 figure was $14654.0, 76.32% down from the prior year.
  • Notes Payables for Q3 2021 was $18900.0 at Silo Pharma, roughly flat from $18900.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $144375.0 in Q1 2020 and bottomed at $7258.0 in Q2 2020.
  • The 3-year median for Notes Payables is $18900.0 (2021), against an average of $35117.4.
  • The largest YoY upside for Notes Payables was 160.4% in 2021 against a maximum downside of 87.65% in 2021.
  • A 3-year view of Notes Payables shows it stood at $61875.0 in 2019, then plummeted by 76.32% to $14654.0 in 2020, then rose by 28.98% to $18900.0 in 2021.
  • Per Business Quant, the three most recent readings for SILO's Notes Payables are $18900.0 (Q3 2021), $18900.0 (Q2 2021), and $17837.0 (Q1 2021).